• Versartis, Aravive enter into merger agreement biospectrumasia
    June 05, 2018
    The transaction will result in a clinical stage, Nadsaq-listed company, based in Houston, Texas, focused on the development of innovative oncology therapeutics.
PharmaSources Customer Service